How neuroinflammation contributes to neurodegeneration
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron’s environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Perturbations in immune function have been demonstrated to exacerbate neurodegeneration and metabolic diseases (Lumeng and Saltiel, 2011; Ransohoff, 2016; Reilly and Saltiel, 2017).”
From Deletion of the Alzheimer’s disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice (2022) · cites this paper as Ransohoff, 2016
In the citing paper
“This excessive inflammatory response occurs in many neurodegenerative disorders such as Parkinson's (PD) and Alzheimer's diseases (AD) (Ransohoff, 2016),(Perry and Holmes, 2014),(Burguillos et al., 2011),(Abeliovich and Gitler, 2016), as well as in neurological conditions such as ischemic stroke (Lambertsen et al., 2012),(Burguillos et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Ransohoff, 2016
In the citing paper
“Neuroinflammation, a CNS-specific process characterized by proinflammatory cellular and molecular changes to microglia, astrocytes, and the BBB, is considered a core feature of aging and age-related neurological conditions, most notably AD, PD, and ALS (155).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [155]
In the citing paper
“Interestingly, a common feature of PD patients and mouse models is the accumulation of activated microglia and astrocytes, which would promote increased local concentrations of inflammatory mediators and ROS (84).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [84]
In the citing paper
“The notion that neuroinflammatory processes contribute to disease was once provocative, yet recent studies have uncovered multiple mechanisms by which aberrant gliosis causes detrimental neuroinflammation that can influence tau pathology and accelerate neurodegeneration.”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [5]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Self-citation
Cited by
Items 501–600 of 1,008
Münch, G. W., Gunawardena, D., & Raju, R. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253529 · Cited by 48
“Inflammation, predominantly caused by activated macrophages and microglia (Ransohoff, 2016), has been suggested to be a major contributing factor for many chronic diseases including neurodegenerative diseases like Alzheimer’s disease (Heneka, 2006).”
Microglia: The Brain's First Responders.
Bilbo, S. D., & Stevens, B. (2017) · PubMed Central · Cited by 61
Zhang, J., Liu, M., Cui, W., Yang, L., & Zhang, C. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.06.058 · Cited by 53
Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases
Li, C. Y., Yang, T. M., Ou, R. W., Wei, Q. Q., & Shang, H. F. (2021) · BMC Medicine · doi:10.1186/s12916-021-01903-y · Cited by 48
Wei, R., Zhang, Y., Feng, Y.-Z., Zhang, K.-X., Zhang, J., Chen, J., Luo, B., Li, X., & Chen, G.-H. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1172091 · Cited by 53
“Accumulating evidence suggests that inflammation can lead to neuronal apoptosis, synaptic remodeling, and alterations in the neuroendocrine system, which, in turn, can result in anxiety and depression (Morris et al., 2015; Ransohoff, 2016; Gopinath et al., 2022).”
BackgroundXu, Y. M., Geng, Y., Wang, H., Zhang, H., Qi, J., Li, F., Hu, X., Chen, Y., Si, H., Li, Y., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102767 · Cited by 53
“According to previous studies, autophagy is an important target for the treatment of CNS diseases and exerts a neuroprotective effect against Y. Xu et al. Redox Biology 64 (2023) 102767 programmed cell death caused by neuroinflammation [52,53].”
BackgroundBlossom, V., Ullal, S. D., D’Souza, M. M., Ranade, A. V., Kumar, N. A., & Rai, R. (2025) · 3 Biotech · doi:10.1007/s13205-025-04468-2 · Cited by 64
“In-depth knowledge about the energetic role of glial cells and peripheral immune cells in different neurological and neuropsychiatric disorders is the need of the hour in the course of discovery of the neurotherapeutics (Ransohoff 2016).”
Tian, L., Hui, C. W., Bisht, K., Tan, Y., Sharma, K. P., Chen, S., Zhang, X., & Tremblay, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.007 · Cited by 52
“…psychological stress and aging potentiate oxidative stress (Miller and Sadeh, 2014; Rodrigues et al., 2014) and neuroinflammation (Cohen et al., 2012), which play together an important role in the pathogenesis of neurodegenerative diseases (Herrup, 2015; Kooi Ong et al., 2016; Ransohoff, 2016b).”
Zhang, L., Xu, J., Gao, J., Wu, Y., Yin, M., & Zhao, W. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0084 · Cited by 47
Qin, Y., Zhang, Y., Tomic, I., Hao, W., Menger, M. D., Liu, C., Fassbender, K. C., & Liu, Y. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180426 · Cited by 50
Mishra, A., Wang, Y., Yin, F., Vitali, F., Rodgers, K. E., Soto, M., Mosconi, L., Wang, T., & Brinton, R. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101542 · Cited by 60
“well-documented contributors to AD (Akhter et al., 2017; Gibson and Shi, 2010; Ransohoff, 2016; Swerdlow, 2018).”
Abrishamdar, M., Jalali, M. S., & Rashno, M. M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02899-z · Cited by 51
Natale, F., Fusco, S., & Grassi, C. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00326-w · Cited by 54
Nanoparticle-Based Strategies to Treat Neuro-Inflammation
Poupot, R., Bergozza, D., & Fruchon, S. (2018) · Materials · doi:10.3390/ma11020270 · Cited by 52
“The scientific community has ow recognized that this chronic euro-inflam ation is a central component in almost all neurological dis rders, either as a caus tive factor o as a secondary player [14,15].”
BackgroundImmunogenetic Factors of Neurodegenerative Diseases: The Role of HLA Class II
Aliseychik, M., Андреева, Т. В., & Rogaev, E. I. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090122 · Cited by 50
In Vitro Priming and Hyper-Activation of Brain Microglia: an Assessment of Phenotypes
Koss, K. M., Churchward, M. A., Tsui, C. T., & Todd, K. G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1529-y · Cited by 50
He, Y., Ruganzu, J. B., Zheng, Q., Wu, X., Jin, H., Peng, X., Ding, B., Lin, C., Ji, S., Ma, Y., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01982-7 · Cited by 51
Ikawa, M., Okazawa, H., Nakamoto, Y., & Yoneda, M. (2020) · Antioxidants · doi:10.3390/antiox9090861 · Cited by 52
Si, X., Fang, Y., Li, L., Gu, L., Yin, X., Jun-Tian, Yan, Y., Pu, J., & Zhang, B. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113525 · Cited by 47
Slater, C. L., & Wang, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.397 · Cited by 50
Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders
Khan, I., Kumari, P., Fernandes, V., Khatri, D. K., & Singh, S. B. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01093-4 · Cited by 52
“The progressive pathogenic events are under inflammatory and neurotoxic mediators (Ransohoff 2016).”
BackgroundChen, X., Feng, Y., Quinn, R. J., Pountney, D. L., Richardson, D. R., Mellick, G. D., & Ma, L. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000743 · Cited by 45
“Although serotonin-and norepinephrine-express-ing neurons within the central nervous system (CNS) can regenerate their cranial projecting axons (Jin et al., 2016; Dougherty et al., 2020), the loss of DA neurons in PD is permanent and irreversible (Ransohoff, 2016).”
BackgroundXia, X., Li, H., Xu, X., Zhao, G., & Du, M. (2023) · ACS Nano · doi:10.1021/acsnano.3c04308 · Cited by 51
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders
Marchi, F. D., Munitić, I., Vidatic, L., Papić, E., Rački, V., Nimac, J., Jurak, I., Novotni, G., Rogelj, B., Vuletić, V., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102793 · Cited by 53
Esmaealzadeh, N., Miri, M. S., Mavaddat, H., Peyrovinasab, A., Zargar, S. G., Kabiri, S. S., Razavi, S. M., & Abdolghaffari, A. H. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01492-1 · Cited by 57
“In this regard, selective neurons have undergone experiments to obtain more information about the molecular pathogenesis of neurodegenerative diseases (Ransohoff 2016).”
Gao, Y., Tu, D., Yang, R., Chu, C., Hong, J., & Gao, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020465 · Cited by 59
van Ton, A. M. P., Verbeek, M. M., Alkema, W. B. L., Pickkers, P., & Abdo, W. F. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.027 · Cited by 49
“Indeed, neuroinflammation has been shown to play a role in both systemic inflammation as well as in neurodegeneration (Heneka et al., 2015; Hoogland et al., 2015; Lemstra et al., 2007; Ransohoff, 2016; Sandiego et al., 2015).”
BackgroundPhytosterols: Targeting Neuroinflammation in Neurodegeneration
Dash, R., Mitra, S., Ali, M. C., Oktaviani, D. F., Hannan, M. A., Choi, S. M., & Moon, I. S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200628022812 · Cited by 47
Bhatia, K., Ahmad, S., Kindelin, A., & Ducruet, A. F. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144348 · Cited by 44
Félix, F. B., Vago, J. P., Beltrami, V. A., Araújo, J. M. D., Grespan, R., Teixeira, M. M., & Pinho, V. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106246 · Cited by 47
IL-17A promotes the progression of Alzheimer’s disease in APP/PS1 mice
Cao, M., Liu, J., Zhang, X., Wang, Y., Hou, Y., Song, Q., Cui, Y., Zhao, Y., & Wang, P. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00397-x · Cited by 49
“A previous study reported the relationship between AD and the immune system; the researchers systematically expounded that activated microglia play an important role in neurodegenerative diseases [18].”
BackgroundTan, Q., Zhang, C., Rao, X., Wan, W., Lin, W. J., Huang, S., Ying, J., Lin, Y., & Hua, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1358719 · Cited by 54
Monda, A., Torre, M. E. L., Messina, A., Maio, G. D., Monda, V., Moscatelli, F., Stefano, M. D., Marra, M. L., di Padova, M., Dipace, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425816 · Cited by 51
Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
D’Ambrosi, N., Cozzolino, M., & Carrì, M. T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7271 · Cited by 47
D’Angiulli, A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00095 · Cited by 49
“, not oneto-one cause-effect (25)] precondition for neurodegeneration (26).”
BackgroundTherapeutic Effect of Modulating TREM-1 via Anti-inflammation and Autophagy in Parkinson’s Disease
Feng, C., Chen, N., Sung, C., Kuo, H., Yang, S., Chen, C., Hung, H.-C., Chen, B., Wen, Z., & Chen, W.-F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00769 · Cited by 45
“Neuroinflammation is primarily mediated by microglial cell over activation, which was suggested to enhance the release of inflammatory enzymes (Ransohoff, 2016; Villegas-Llerena et al., 2016).”
Newby, D., Prieto‐Alhambra, D., Duarte‐Salles, T., Ansell, D., Pedersen, L. H., van der Lei, J., Mosseveld, M., Rijnbeek, P. R., James, G., Alexander, M., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00606-5 · Cited by 47
Zhao, J., Li, H., & Chang, N. (2020) · EXCLI journal · doi:10.17179/excli2020-2286 · Cited by 44
The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity
Chen, J., Xu, J., Huang, P., Luo, Y., Shi, Y., & Ma, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112866 · Cited by 48
In vivo PET imaging of neuroinflammation in familial frontotemporal dementia
Malpetti, M., Rittman, T., Jones, P. S., Cope, T. E., Passamonti, L., Bevan-Jones, W. R., Patterson, K., Fryer, T. D., Hong, Y. T., Aigbirhio, F. I., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323698 · Cited by 43
Jana, A., Wang, X., Leasure, J. W., Magana, L., Wang, L., Kim, Y.-M., Dodiya, H., Toth, P. T., Sisodia, S. S., & Rehman, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-20889-y · Cited by 43
The role of high mobility group box 1 in neuroinflammatory related diseases
Mo, J., Hu, J., & Cheng, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114541 · Cited by 51
Kann, O. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15867 · Cited by 46
“The activation of microglia— the resident macrophages in the CNS— is a major hallmark in neuroinflammation (Borst et al., 2021; Colonna & Butovsky, 2017; Kumar, 2019; Ransohoff, 2016).”
BackgroundPropofol inhibits neuroinflammation and metabolic reprogramming in microglia in vitro and in vivo
Guan, S., Sun, L., Wang, X., Huang, X., & Luo, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1161810 · Cited by 49
“Neuroinflammation and neuronal death can be heavily caused by sepsis (Gao et al., 2011; Ransohoff, 2016; Joers et al., 2017; Hickman et al., 2018); these can even be”
BackgroundChen, X., Yuan, Q., Wang, X., Tang, Z., Xu, J., Lin, H. Y., Yang, Z., Song, X., Lü, D., Guo, J., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12825 · Cited by 46
Quercetin attenuates AZT-induced neuroinflammation in the CNS
Yang, Y., Liu, X., Wu, T., Zhang, W., Shu, J., He, Y., & Tang, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-24618-2 · Cited by 49
Raikwar, S. P., Kikkeri, N. S., Sakuru, R. C., Saeed, D., Zahoor, H., Premkumar, K., Mentor, S., Thangavel, R., Dubova, I., Ahmed, M. E., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09849-y · Cited by 54
“Neuroinflammation plays a very crucial role in the etiopathogenesis of various neurodegenerative diseases (Ransohoff 2016; Becher et al. 2017).”
Decourt, B., Wilson, J., Ritter, A., Dardis, C., DiFilippo, F., Zhuang, X., Cordes, D., Lee, G., Fulkerson, N., St Rose, T., et al. (2020) · Open Access Journal of Clinical Trials · doi:10.2147/oajct.s221914 · Cited by 43
“Keywords Alzheimer’s disease; biomarkers; brain amyloid; brain imaging; clinical trial; cognition; cytokines; dementia; hematologic changes; immunomodulation; inflammation; lenalidomide Introduction Currently, there are no FDA-approved medications indicated for the treatment of AD.”
BackgroundParkinson’s Disease, Periodontitis and Patient-Related Outcomes: A Cross-Sectional Study
Lyra, P., Machado, V., Proença, L., Domingos, J., Godinho, C., Mendes, J. J., & Botelho, J. (2020) · Medicina · doi:10.3390/medicina56080383 · Cited by 55
“Accumulating evidence has shed light on how neuroinflammation can play a key role on the PD pathogenesis and neurodegeneration [45,46].”
BackgroundMelatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux
Farré‐Alins, V., Narros‐Fernández, P., Palomino‐Antolín, A., Decouty‐Pérez, C., López-Rodríguez, A. B., Parada, E., Muñoz-Montero, A., Gómez‐Rangel, V., Lopez-Munoz, F. J., Ramos, E., et al. (2020) · Antioxidants · doi:10.3390/antiox9121299 · Cited by 51
“However, uncontrolled inflammation can be harmful, leading to tissue damage and the development of inflammatory and/or autoimmune diseases [1].”
BackgroundEarly intervention attenuates synaptic plasticity impairment and neuroinflammation in 5xFAD mice
Li, K., Wang, X., Jiang, Y., Zhang, X., Liu, Z., Yin, T., & Yang, Z. R. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.007 · Cited by 48
Lv, K., Liu, Y., Zheng, Y., Shaowen, D., Yin, P., & Miao, H. (2021) · Biological Research · doi:10.1186/s40659-021-00332-8 · Cited by 43
“There is numerous evidence suggesting that neuroinflammation is related to neurodegeneration in diverse neurological diseases [5].”
BackgroundYang, X., Zhang, Y., Chen, Y., He, X., Qian, Y., Xu, S., Gao, C., Mo, C., Chen, S., & Xiao, Q. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02267-z · Cited by 46
“Microglia-mediated neuroinflammation is a prominent feature shared by various neurodegenerative diseases, such as Parkinson’s disease (PD), Alzheimer’s disease (AD), and amyotrophic lateral sclerosis (ALS) [27, 28].”
BackgroundThe Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement
Zhang, H., Yao, L., Zheng, Z., Koç, S., & Lu, G. (2022) · Pharmaceuticals · doi:10.3390/ph15070811 · Cited by 45
Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential
Mi, Y., Qi, G., Brinton, R. D., & Yin, F. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8070 · Cited by 43
“Neuroinflammation is characterized by infiltration of immune cells, activation of glial cells, and production of inflammatory mediators in the nervous system, and has been increasingly recognized as a major contributor to neurodegeneration disease, including AD (141).”
BackgroundFunctional and Therapeutic Potential of Cynara scolymus in Health Benefits
Porro, C., Benameur, T., Cianciulli, A., Vacca, M., Chiarini, M., Angelis, M. D., & Panaro, M. A. (2024) · Nutrients · doi:10.3390/nu16060872 · Cited by 55
“Neurons perform essential functions such as signal transmission and information integration in the central nervous system, making them the main targets of neurodegenerative diseases [93].”
BackgroundTorniainen‐Holm, M., Suvisaari, J., Lindgren, M., Härkänen, T., Dickerson, F., & Yolken, R. H. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.01.006 · Cited by 47
Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease
Galet, B., Cheval, H., & Ravassard, P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01005 · Cited by 52
“In the context of PD, coculturing hMO with microglia-like and endothelial cells could for example enable researchers to study neuroinflammatory mechanisms involving glial activation and brain-blood-barrier disruption (133).”
BackgroundExperimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease: An Updated Review
Yu, C.-C., Du, Y., Wang, S., Liu, L.-B., Shen, F., Wang, L., Lin, Y.-F., & Kong, L.-H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.549772 · Cited by 47
“Neuroinflammation The critical role of neuroinflammation in the pathogenesis of AD has been extensively discussed in previous reviews (Heneka et al., 2015; Calsolaro and Edison, 2016; Ransohoff, 2016).”
BackgroundWelcome, M. O. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100176 · Cited by 44
P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis
Ruiz‐Ruiz, C., Calzaferri, F., & García, A. G. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00093 · Cited by 43
“How neuroinflammation contributes to neurodegeneration has recently been analyzed by Ransohoff (2016).”
BackgroundTripathi, S., Shree, B., Mohapatra, S., Swati, S., Basu, A., & Sharma, V. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02268-8 · Cited by 48
Neuroinflammation is highest in areas of disease progression in semantic dementia
Pascual, B., Funk, Q., Zanotti‐Fregonara, P., Cykowski, M. D., Veronese, M., Rockers, E., Bradbury, K., Yu, M., Nakawah, M. O., Román, G. C., et al. (2021) · Brain · doi:10.1093/brain/awab057 · Cited by 45
Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
Vasincu, A., Rusu, R.-N., Ababei, D. C., Larion, M., Bild, W., Stanciu, G. D., Solcan, C., & Bild, V. (2022) · Biology · doi:10.3390/biology11030440 · Cited by 54
“The neurodegenerative processes behind these disorders occur in the CNS and are associated with the alteration of neuronal morphology and functionality, thus leading to functional and mental impairment due to reduced neuronal survival and increased neuronal death [8,9].”
BackgroundSIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson's disease
Yang, Y., Zhang, S., Guan, J., Jiang, Y., Zhang, J., Luo, L., & Sun, C. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166365 · Cited by 41
Neuroinflammation in Friedreich’s Ataxia
Apolloni, S., Milani, M., & D’Ambrosi, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116297 · Cited by 41
“In different neurodegenerative conditions with a robust neuroinflammatory component, contrasting neuroinflammation has been proven to be one of the most efficient ways to slow down disease progression [9].”
BackgroundLiu, Z., Shen, C., Li, H., Tong, J., Wu, Y., Ma, Y., Wang, J., Wang, Z., Li, Q. X., Zhang, X., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02755-4 · Cited by 42
“Due to the activation of microglia and astrocytes, the levels of proinflammatory molecules, including IL-1β, IL-6, TNF-α, iNOS and ROS, are elevated in the nigrostriatal system of postmortem human samples, increasing the risk of dopaminergic neuronal degeneration [5, 58].”
BackgroundInfection and chronic disease activate a systemic brain-muscle signaling axis
Yang, S., Tian, M., Dai, Y., Wang, R., Yamada, S., Feng, S., Wang, Y., Chhangani, D., Ou, T., Li, W., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adm7908 · Cited by 60
Kang, Y., Mozley, P. D., Verma, A., Schlyer, D., Henchcliffe, C., Gauthier, S. A., Chiao, P. C., He, B., Nikolopoulou, A., Logan, J., et al. (2018) · Journal of Neuroimaging · doi:10.1111/jon.12519 · Cited by 40
“Journal Journal of neuroimaging : official journal of the American Society of Neuroimaging, 28(5)”
BackgroundFragola, G., Mabb, A. M., Taylor‐Blake, B., Niehaus, J. K., Chronister, W. D., Mao, H., Simon, J. M., Yuan, H., Li, Z., McConnell, M. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15794-9 · Cited by 45
Multiple Sclerosis: Lipids, Lymphocytes, and Vitamin D
Hayes, C. E., & Ntambi, J. M. (2020) · Immunometabolism · doi:10.20900/immunometab20200019 · Cited by 44
“Close examination of MS demyelinating lesions has revealed an inflammatory process that causes CNS tissue injury at all stages of MS disease [7,8].”
BackgroundStem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
Si, Z., & Wang, X. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000324 · Cited by 46
“When MSCs enter the neuroinflammatory milieu, they will release proinflammatory and anti-inflammatory factors, and activated T cells can interact with neuronal cells to reduce neuronal death (Ransohoff, 2016).”
BackgroundMishra, M. K., Rawji, K. S., Keough, M. B., Kappen, J., Dowlatabadi, R., Vogel, H. J., Chopra, S., Distéfano‐Gagné, F., Dufour, A., Gosselin, D., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1948-20.2021 · Cited by 44
“Blood-derived macrophages originate as circulating monocytes that migrate into sites of injury where they fulfill diverse functions, including phagocytosis of debris, provision of various growth factors, and scar formation (Raposo and Schwartz, 2014; Ransohoff, 2016; Prinz and Priller, 2017).”
Kozina, E. A., Byrne, M. D., & Smeyne, R. J. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00289-9 · Cited by 43
Huang, P., & Zhang, M. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00905-x · Cited by 47
“Misfolded and aggregated proteins in various NDs can also trigger neuroinflammation, characterized by a reactive morphology of both astrocytes and microglial cells [25].”
BackgroundBai, Y., Zhou, J., Zhu, H., Tao, Y., Wang, L., Liu, Y., Wu, H., Huang, F., Shi, H., & Wu, X. (2022) · Phytotherapy Research · doi:10.1002/ptr.7665 · Cited by 44
“Neuroinflammation in PD is typically characterized by the reactive morphology of glial cells along with inflammatory mediators in the parenchyma (Ransohoff, 2016).”
BackgroundThe JAK-STAT Signaling Pathway in Epilepsy
Sun, H., Ma, D., Cheng, Y., Li, J., Zhang, W., Jiang, T., Li, Z., Li, X., & Meng, H. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221214170234 · Cited by 44
Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults
Lopes, K. D. P., Yu, L., Shen, X., Qiu, Y., Tasaki, S., Iatrou, A., Beeri, M. S., Seyfried, N. T., Menon, V., Wang, Y., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13474 · Cited by 41
Sánchez-Cruz, A., Villarejo‐Zori, B., Marchena, M., Zaldívar-Díez, J., Palomo, V., Gil, C., Lizasoaín, I., de la Villa, P., Martínez, A., de la Rosa, E. J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0251-y · Cited by 38
Bennett, J. P., Keeney, P. M., & Brohawn, D. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00235 · Cited by 39
“…al., 2016; Beamer et al., 2016; Calsolaro and Edison, 2016; Casas et al., 2016; Chen S.H. et al., 2016; Chen W.W et al., 2016; Puentes et al., 2016; Ransohoff, 2016; Rothaug et al., 2016; Su et al., 2016; Toledano et al., 2016; Trias et al., 2016; Ulrich and Holtzman, 2016; Wes et al., 2016; Au…”
Li, S., Zhou, Y., He, D., Liu, W., Fan, X., Wang, Q., Pan, H., Cheng, Y., & Liu, Y. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153164 · Cited by 39
Myelin Plasticity and Repair: Neuro-Glial Choir Sets the Tuning
Ronzano, R., Thétiot, M., Lubetzki, C., & Desmazières, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00042 · Cited by 45
“They can adopt different phenotypes, with environmentdependent transcriptional profiles (Gosselin et al., 2014, 2017), and proinflammatory to pro-regenerative polarization (Miron and Franklin, 2014), though a strict dichotomy is an inadequate vision (Ransohoff, 2016).”
BackgroundZhang, C., Hu, L., Liu, D., Huang, J., & Lin, W. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00760 · Cited by 42
“Prolonged activation of microglia resulted in a state of neurotoxicity in which overproduction of proinflammatory cytokines are harmful for neurons (Ransohoff, 2016; Hickman et al., 2018).”
BackgroundLong Non-coding RNAs in Parkinson’s Disease
Xin, C., & Liu, J. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03230-3 · Cited by 46
Detrimental effects of long-term elevated serum uric acid on cognitive function in rats
Tian, T., Liu, X.-R., Li, T., Nie, Z., Li, S., Tang, Y., Gu, C., Xu, W., & Jia, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-86279-y · Cited by 42
Gougeon, M.-L., Poirier-Beaudouin, B., Ausseil, J., Zérah, M., Artaud, C., Heard, J.-M., Deiva, K., & Tardieu, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655478 · Cited by 38
“, microglia, astrocytes, oligodendrocytes), or from outside of the CNS and mediated by infiltrating peripheral T cells, breakdown of the blood–brain barrier, pro-inflammatory cytokines and other mechanisms (52).”
BackgroundMockenhaupt, K., Gonsiewski, A. K., & Kordula, T. (2021) · Cells · doi:10.3390/cells10071609 · Cited by 46
Tisdall, M. D., Ohm, D. T., Lobrovich, R., Das, S. R., Mizsei, G., Prabhakaran, K., Ittyerah, R., Lim, S., McMillan, C. T., Wolk, D. A., et al. (2022) · NeuroImage: Clinical · doi:10.1016/j.nicl.2021.102913 · Cited by 38
“(Heppner et al., 2015; Ransohoff, 2016) The large iron-rich ameboid morphologies seen in areas of high-pathology in 4R tauopathies suggest the pro-inflammatory state may involve iron sequestration from phagocytosis of cellular debris.”
DNA Damage-Mediated Neurotoxicity in Parkinson’s Disease
Wang, Z., Li, Y., Pu, J., & Zhang, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076313 · Cited by 46
The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases
Liu, N., Lin, M., & Wang, Y. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03063-3 · Cited by 43
“Neuroinflammation is one of the typical pathological features of PD [138].”
BackgroundXu, N., Bai, Y., Han, X., Yuan, J., Wang, L., He, Y., Liu, Y., Wu, H., Shi, H., & Wu, X. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152388 · Cited by 39
Thrombin, a Key Driver of Pathological Inflammation in the Brain
Iannucci, J., & Grammas, P. (2023) · Cells · doi:10.3390/cells12091222 · Cited by 44
“While each of these diseases is characterized by unique patterns of neurodegeneration, as well as pathognomonic protein abnormalities which determine clinical presentation, neuroinflammation is an invariant feature of these disorders [4,5].”
BackgroundMisrani, A., Tabassum, S., Zhang, Z.-Y., Tan, S.-H., & Long, C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03651-x · Cited by 41
“Neuroinflammation is a complex pro - cess that involves cellular and molecular alterations, activation of a few intracellular signaling pathways, and release of inflammatory mediators in the brain, which can lead to neuronal dysfunction and even death [9, 10].”
Hou, L., Zhang, L., Hong, J., Zhang, D., Zhao, J., & Wang, Q. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8014 · Cited by 40
Lee, H.-J., Woo, H., Lee, H.-E., Jeon, H., Ryu, K.-Y., Nam, J. H., Jeon, S. G., Park, H., Lee, J.-S., Han, K.-M., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.030 · Cited by 36
Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein
Li, N., Stewart, T., Sheng, L., Shi, M. Y., Cilento, E. M., Wu, Y., Hong, J.-S., & Zhang, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01940-z · Cited by 36
FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK/STAT signaling pathway
Wang, L., Zhao, D., Wang, H., Wang, L., Liu, X., & Zhang, H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108117 · Cited by 42
Morales-Prieto, D. M., Murrieta-Coxca, J. M., Stojiljkovic, M., Diezel, C., Streicher, P. E., Henao-Restrepo, J. A., Röstel, F., Lindner, J., Witte, O. W., Weis, S., et al. (2022) · Cells · doi:10.3390/cells11040625 · Cited by 38
“Consistently, neuroinflammation is characterized by glial activation and proinflammatory cytokine production by the central nervous system (CNS) resident cells [6].”
BackgroundReis, P. A., & Castro-Faria-Neto, H. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742158 · Cited by 41
“With that in mind, NG2 cells can be proposed as a target to regulate neuroinflammatory conditions in major neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (later stages of the disease) (Ransohoff, 2016).”
BackgroundNon-coding RNAs: The Neuroinflammatory Regulators in Neurodegenerative Diseases
Jiang, H., Zhang, Y., Yue, J., Shi, Y., Xiao, B., Xiao, W., & Luo, Z. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.929290 · Cited by 40
“Some studies show that the related changes caused by neuroinflammation may promote the occurrence and development of neurodegenerative diseases (8).”
Background
Metadata
- Authors
- Ransohoff, R. M.
- Affiliations
- Biogen (United States) (US)
- Corresponding author
- Ransohoff, Richard M.
- Venue
- Science
- Published
- 2016-08-19
- Volume
- 353
- Issue
- 6301
- Pages
- 777-783
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2517534055
- Semantic Scholar
- bfcfccbbc79f79cab04ba4617a0680c58ddb26a2
- Cited by
- 1,967
- References
- 87
- Citations by year
- 2026: 178 · 2025: 182 · 2024: 191 · 2023: 197 · 2022: 241 · 2021: 262 · 2020: 213 · 2019: 192 · 2018: 166 · 2017: 130 · 2016: 11
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neuroinflammation, neurodegeneration, glial cells, blood-brain barrier, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal lobar dementia
- MeSH terms
- CX3C Chemokine Receptor 1, Blood-Brain Barrier, Humans, Inflammation, Membrane Glycoproteins, Neurons, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Receptors, Chemokine, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.